Edition:
Deutschland

Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

7,079JPY
6 Dec 2019
Change (% chg)

¥-15 (-0.21%)
Prev Close
¥7,094
Open
¥7,071
Day's High
¥7,164
Day's Low
¥7,051
Volume
1,423,100
Avg. Vol
1,726,799
52-wk High
¥7,358
52-wk Low
¥3,277

About

DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the... (more)

Buy/Sell

Sell Hold Buy
2.08 Mean rating from 13 analysts

Overall

Beta: 0.93
Market Cap(Mil.): ¥5,019,092.00
Shares Outstanding(Mil.): 709.01
Dividend: 35.00
Yield (%): 0.99

BRIEF-EMA Says CHMP Recommends Conditional Marketing Authorisation For Ebola Vaccine Ervebo

* CHMP RECOMMENDS GRANTING CONDITIONAL MARKETING AUTHORISATION FOR ERVEBO FOR ACTIVE IMMUNISATION OF PEOPLE ABOVE 18 YEARS AT RISK OF EBOLA VIRUS

UPDATE 1-AstraZeneca breast cancer treatment gets FDA priority review

Oct 17 AstraZeneca Plc said on Thursday that the U.S. drug regulator will give a speedy review to its experimental breast cancer treatment, which could put the British drugmaker in direct competition with bigger rival Roche Holding AG. The U.S. Food and Drug Administration (FDA) accepted AstraZeneca's application and granted the treatment, trastuzumab deruxtecan, a priority review for the treatment of HER2-positive metastatic breast cancer, the drugmaker said.

AstraZeneca gets FDA priority review for experimental breast cancer drug

Oct 17 Drugmaker AstraZeneca Plc said on Thursday its experimental breast cancer treatment will get a speedy review by the U.S. Food and Drug Administration, with a decision by the health regulator expected in the second quarter of next year.

Japan stocks end higher on hopes for U.S.-China thaw

TOKYO, Oct 10 Japanese stocks bounced back from early losses to end higher on Thursday, helped by a flush of optimism over chances that the United States and China can scale back their trade war at high-level talks set for later in the day.

Japan shares at 6-week high as banks, exporters, Apple suppliers shine

TOKYO, Sept 11 Japanese stocks rose to a six-week high on Wednesday as bank shares extended recent gains thanks to rising bond yields, while major exporters reaped the rewards of a faltering yen.

CORRECTED-UPDATE 1-AstraZeneca's Tagrisso helps lung cancer patients live longer- study (Aug. 9)

Sept 4 AstraZeneca Plc said on Friday a late-stage study showed its top-selling drug, Tagrisso, had significantly helped patients with a type of lung cancer live longer.

CORRECTED-UPDATE 1-AstraZeneca's Tagrisso helps lung cancer patients live longer- study (Aug. 9)

Aug 9 AstraZeneca Plc said on Friday a late-stage study showed its top-selling drug, Tagrisso, had significantly helped patients with a type of lung cancer live longer.

CORRECTED-AstraZeneca's Tagrisso gets China OK for type of lung cancer

Sept 4 AstraZeneca Plc said on Wednesday it had received marketing authorisation from China's National Medical Products Administration for its top-selling drug, Tagrisso, to treat adults with a form of lung cancer.

UPDATE 2-GSK builds oncology pipeline as drug shown to help myeloma patients

* Result a fillip for GSK's comeback bid in oncology (Adds detail on class of drugs, rivals)

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.68%
Rohstoffe +0.93%
Industrie +0.59%
Konjunktur abhängige Waren & Dienstleistungen +0.56%
Konjunktur unabhängige Waren & Dienstleistungen +0.87%
Finanzindustrie +0.54%
Pharma +0.97%
Technologie +0.28%
Telekommunikation -0.03%

Nachrichten aus der Wirtschaft

Photo

Schweizer Börse legt zu - Swiss Re nach Spartenverkauf gesucht

Zürich Gute US-Konjunkturdaten haben der Schweizer Börse zum Wochenschluss Schub verliehen. Der SMI gewann rund ein Prozent auf 10.463 Punkte. Der stärkste Stellenaufbau in den USA seit zehn Monaten zeigte Händler zufolge, dass der US-Arbeitsmarkt in besserer Verfassung ist erwartet. Trotz des Schlussspurts verbuchte der Leitindex im Verlauf der gesamten Woche ein Minus von rund 0,3 Prozent.